Subscribe Login
A-Brands

Johnson & Johnson Promises Vaccine Data 'Soon'

Johnson & Johnson said on Tuesday it would share details from its widely watched coronavirus vaccine trial soon, as the healthcare conglomerate races to develop a potential single-dose vaccine for COVID-19.

Data from Johnson & Johnson's single-dose COVID-19 shot is expected this month, with global hopes to battle the virus riding on multiple vaccines to ensure adequate supply.

In the latest setback to the effort, rival Merck & Co said on Monday it was discontinuing the development of both its COVID-19 vaccines.

Johnson & Johnson also forecast 2021 adjusted profit of between $9.40 and $9.60 per share after its fourth-quarter sales rose to $22.48 billion from $20.75 billion.

News by Reuters edited by Checkout. Click subscribe to sign up for the Checkout print edition.

Stay Connected With Our Weekly Newsletter

Processing your request...

Thanks! please check your email to confirm your subscription.

LIMITED TIME OFFER: 20% Off Our Premium Subscription
Enjoy full access to all website and app content, our weekly email news digest, and to Checkout Magazine 12 times a year (including our Top 100 Brands 2022 edition).
LIMITED TIME OFFER: 20% Off Our Premium Subscription
LIMITED TIME OFFER: 20% Off Our Premium Subscription
Enjoy full access to all website and app content, our weekly email news digest, and to Checkout Magazine 12 times a year (including our Top 100 Brands 2022 edition).
LIMITED TIME OFFER: 20% Off Our Premium Subscription